company background image
4732

NatureWise Biotech & Medicals TPEX:4732 Stock Report

Last Price

NT$30.60

Market Cap

NT$1.5b

7D

1.7%

1Y

43.7%

Updated

30 Sep, 2022

Data

Company Financials
4732 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

4732 Stock Overview

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan.

NatureWise Biotech & Medicals Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for NatureWise Biotech & Medicals
Historical stock prices
Current Share PriceNT$30.60
52 Week HighNT$54.50
52 Week LowNT$19.55
Beta0.59
1 Month Change1.66%
3 Month Change14.18%
1 Year Change43.66%
3 Year Change31.85%
5 Year Change103.49%
Change since IPO77.54%

Recent News & Updates

Apr 29
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

With a price-to-earnings (or "P/E") ratio of 16.8x NatureWise Biotech & Medicals Corporation ( GTSM:4732 ) may be...

Shareholder Returns

4732TW Personal ProductsTW Market
7D1.7%-5.8%-5.5%
1Y43.7%-6.2%-19.3%

Return vs Industry: 4732 exceeded the TW Personal Products industry which returned -6.2% over the past year.

Return vs Market: 4732 exceeded the TW Market which returned -19.3% over the past year.

Price Volatility

Is 4732's price volatile compared to industry and market?
4732 volatility
4732 Average Weekly Movement5.9%
Personal Products Industry Average Movement5.9%
Market Average Movement5.2%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 4732 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 4732's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2000n/aChung-Yang Huanghttps://www.naturewise.com.tw

NatureWise Biotech & Medicals Corporation engages in the development of therapeutic drugs in Taiwan. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; PPL products comprise Taiwanese Green Propolis; and NBM-BMX an oral Softgel capsule to treat cancer. The company was founded in 2000 and is based in Taipei City, Taiwan.

NatureWise Biotech & Medicals Corporation Fundamentals Summary

How do NatureWise Biotech & Medicals's earnings and revenue compare to its market cap?
4732 fundamental statistics
Market CapNT$1.51b
Earnings (TTM)NT$62.53m
Revenue (TTM)NT$292.80m

24.1x

P/E Ratio

5.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
4732 income statement (TTM)
RevenueNT$292.80m
Cost of RevenueNT$122.29m
Gross ProfitNT$170.50m
Other ExpensesNT$107.97m
EarningsNT$62.53m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.27
Gross Margin58.23%
Net Profit Margin21.36%
Debt/Equity Ratio0%

How did 4732 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

24%

Payout Ratio